PHP
VCYT icon

Parkman Healthcare Partners’s Veracyte VCYT Stock Holding History

Parkman Healthcare Partners’s Portfolio VCYT Stock Details VCYT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-101,237
Closed -$3.26M – 105
2026
Q1 		$3.26M Buy
101,237
+968
+1% +$35.8K 0.34% 74
2025
Q4 		$4.22M Sell
100,269
-122,796
-55% -$4.95M 0.4% 67
2025
Q3 		$7.66M Buy
223,065
+2,678
+1% +$76.8K 0.8% 47
2025
Q2 		$5.96M Buy
220,387
+54,109
+33% +$1.57M 0.68% 55
2025
Q1 		$4.93M Buy
166,278
+65,977
+66% +$2.51M 0.58% 50
2024
Q4 		$3.97M Sell
100,301
-28,959
-22% -$1.1M 0.53% 50
2024
Q3 		$4.4M Sell
129,260
-80,215
-38% -$2.26M 0.56% 58
2024
Q2 		$4.54M Sell
209,475
-44,617
-18% -$938K 0.61% 58
2024
Q1 		$5.63M Buy
254,092
+16,776
+7% +$409K 0.69% 49
2023
Q4 		$6.53M Buy
237,316
+11,444
+5% +$276K 0.92% 36
2023
Q3 		$5.04M Buy
225,872
+13,912
+7% +$358K 0.92% 36
2023
Q2 		$5.4M Buy
211,960
+93,338
+79% +$2.26M 0.94% 33
2023
Q1 		$2.65M Buy
118,622
+896
+0.8% +$21.7K 0.58% 51
2022
Q4 		$2.79M Buy
117,726
+56,843
+93% +$1.32M 0.74% 50
2022
Q3 		$1.01M Sell
60,883
-13,083
-18% -$294K 0.29% 70
2022
Q2 		$1.47M Buy
73,966
+13,315
+22% +$269K 0.54% 50
2022
Q1 		$1.67M Sell
60,651
-1,613
-3% -$46.1K 0.49% 51
2021
Q4 		$2.56M Buy
62,264
+17,264
+38% +$763K 0.57% 46
2021
Q3 		$2.09M Buy
+45,000
New +$1.96M 0.53% 52

Other funds holding VCYT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Parkman Healthcare Partners's VCYT Position: Q2 2026 in Review

Parkman Healthcare Partners sold out of Veracyte (VCYT) in Q2 2026, closing a stake of 101,237 shares — an estimated $3.26M sold.

Parkman Healthcare Partners first reported a position in VCYT in Q3 2021 and held it in 19 quarters. The position peaked at $7.66M in Q3 2025. 370 funds tracked by Wall St. Rank hold VCYT as of Q2 2026.

  • Parkman Healthcare Partners reported no remaining Veracyte position as of Q2 2026 after selling out during the quarter.
  • Parkman Healthcare Partners sold 101,237 Veracyte shares in Q2 2026, an estimated $3.26M.
  • Parkman Healthcare Partners first reported a position in Veracyte in Q3 2021 and held it in 19 quarters.
  • Parkman Healthcare Partners's Veracyte position peaked at $7.66M in Q3 2025.
  • 370 funds tracked by Wall St. Rank held Veracyte as of Q2 2026.

Based on Parkman Healthcare Partners's 13F filing for Q2 2026, filed 14 Aug 2026.